Selcukbiricik, Fatih <br/><br/>
Elevation in serum uric acid levels predicts favourable response to erlotinib treatment in patients with metastatic non-small-cell lung cancer.  [electronic resource] 

 -  Journal of clinical pharmacy and therapeutics  Apr 2020 
 - 303-308 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study 
<br/><br/><label>ISSN: </label>1365-2710 
<br/><br/><label>Standard No.: </label>10.1111/jcpt.13071  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Biomarkers, Tumor--blood<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Cohort Studies<br/>Disease Progression<br/>ErbB Receptors--antagonists & inhibitors<br/>Erlotinib Hydrochloride--administration & dosage<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Protein Kinase Inhibitors--administration & dosage<br/>Retrospective Studies<br/>Treatment Outcome<br/>Uric Acid--blood